Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression.

Noto JM, Rose KL, Hachey AJ, Delgado AG, Romero-Gallo J, Wroblewski LE, Schneider BG, Shah SC, Cover TL, Wilson KT, Israel DA, Roa JC, Schey KL, Zavros Y, Piazuelo MB, Peek RM Jr.

Mol Cell Proteomics. 2019 Feb;18(2):352-371. doi: 10.1074/mcp.RA118.001181. Epub 2018 Nov 19.

PMID:
30455363
2.

Helicobacter pylori genetic diversification in the Mongolian gerbil model.

Beckett AC, Loh JT, Chopra A, Leary S, Lin AS, McDonnell WJ, Dixon BREA, Noto JM, Israel DA, Peek RM Jr, Mallal S, Algood HMS, Cover TL.

PeerJ. 2018 May 18;6:e4803. doi: 10.7717/peerj.4803. eCollection 2018.

3.

Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments.

Noto JM, Chopra A, Loh JT, Romero-Gallo J, Piazuelo MB, Watson M, Leary S, Beckett AC, Wilson KT, Cover TL, Mallal S, Israel DA, Peek RM.

Gut. 2018 Oct;67(10):1793-1804. doi: 10.1136/gutjnl-2017-313863. Epub 2017 Sep 18.

4.

Draft Genome Sequences of 13 Colombian Helicobacter pylori Strains Isolated from Pacific Coast and Andean Residents.

Pazos A, Kodaman N, Piazuelo MB, Romero-Gallo J, Sobota RS, Israel DA, Bravo LE, Morgan DR, Wilson KT, Correa P, Peek RM Jr, Williams SM, Schneider BG.

Genome Announc. 2017 Apr 13;5(15). pii: e00113-17. doi: 10.1128/genomeA.00113-17.

5.

Draft Genome Sequence of Gerbil-Adapted Carcinogenic Helicobacter pylori Strain 7.13.

Asim M, Chikara SK, Ghosh A, Vudathala S, Romero-Gallo J, Krishna US, Wilson KT, Israel DA, Peek RM Jr, Chaturvedi R.

Genome Announc. 2015 Jun 11;3(3). pii: e00641-15. doi: 10.1128/genomeA.00641-15.

6.

Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.

Chaturvedi R, de Sablet T, Asim M, Piazuelo MB, Barry DP, Verriere TG, Sierra JC, Hardbower DM, Delgado AG, Schneider BG, Israel DA, Romero-Gallo J, Nagy TA, Morgan DR, Murray-Stewart T, Bravo LE, Peek RM Jr, Fox JG, Woster PM, Casero RA Jr, Correa P, Wilson KT.

Oncogene. 2015 Jun;34(26):3429-40. doi: 10.1038/onc.2014.273. Epub 2014 Sep 1.

7.

Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells.

Wroblewski LE, Piazuelo MB, Chaturvedi R, Schumacher M, Aihara E, Feng R, Noto JM, Delgado A, Israel DA, Zavros Y, Montrose MH, Shroyer N, Correa P, Wilson KT, Peek RM Jr.

Gut. 2015 May;64(5):720-30. doi: 10.1136/gutjnl-2014-307650. Epub 2014 Aug 14.

8.

Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells.

Wang L, Cao H, Lu N, Liu L, Wang B, Hu T, Israel DA, Peek RM Jr, Polk DB, Yan F.

PLoS One. 2013;8(2):e56666. doi: 10.1371/journal.pone.0056666. Epub 2013 Feb 14.

9.

The effects of health care benefits on health care use and health: a randomized trial for disability insurance beneficiaries.

Michalopoulos C, Wittenburg D, Israel DA, Warren A.

Med Care. 2012 Sep;50(9):764-71. doi: 10.1097/MLR.0b013e31825a8bfc.

PMID:
22643198
10.

Effect of Helicobacter pylori cdrA on interleukin-8 secretions and nuclear factor kappa B activation.

Takeuchi H, Zhang YN, Israel DA, Peek RM Jr, Kamioka M, Yanai H, Morimoto N, Sugiura T.

World J Gastroenterol. 2012 Feb 7;18(5):425-34. doi: 10.3748/wjg.v18.i5.425.

11.

Cell-associated hemolysis induced by Helicobacter pylori is mediated by phospholipases with mitogen-activated protein kinase-activating properties.

Sitaraman R, Israel DA, Romero-Gallo J, Peek RM Jr.

J Clin Microbiol. 2012 Mar;50(3):1014-8. doi: 10.1128/JCM.05252-11. Epub 2012 Jan 11.

12.

Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice.

Yan F, Wang L, Shi Y, Cao H, Liu L, Washington MK, Chaturvedi R, Israel DA, Cao H, Wang B, Peek RM Jr, Wilson KT, Polk DB.

Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G504-14. doi: 10.1152/ajpgi.00312.2011. Epub 2011 Dec 15.

13.

Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA.

Chaturvedi R, Asim M, Romero-Gallo J, Barry DP, Hoge S, de Sablet T, Delgado AG, Wroblewski LE, Piazuelo MB, Yan F, Israel DA, Casero RA Jr, Correa P, Gobert AP, Polk DB, Peek RM Jr, Wilson KT.

Gastroenterology. 2011 Nov;141(5):1696-708.e1-2. doi: 10.1053/j.gastro.2011.07.045. Epub 2011 Aug 10.

14.

FDG uptake in lipomatous hypertrophy of the interatrial septum is not likely related to brown adipose tissue.

Zukotynski KA, Israel DA, Kim CK.

Clin Nucl Med. 2011 Sep;36(9):767-9. doi: 10.1097/RLU.0b013e318219b353.

PMID:
21825845
15.

╬▓-Catenin and p120 mediate PPAR╬┤-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia.

Nagy TA, Wroblewski LE, Wang D, Piazuelo MB, Delgado A, Romero-Gallo J, Noto J, Israel DA, Ogden SR, Correa P, Cover TL, Peek RM Jr.

Gastroenterology. 2011 Aug;141(2):553-64. doi: 10.1053/j.gastro.2011.05.004. Epub 2011 May 17.

16.

Helicobacter pylori induction of eosinophil migration is mediated by the cag pathogenicity island via microbial-epithelial interactions.

Nagy TA, Allen SS, Wroblewski LE, Flaherty DK, Slaughter JC, Perez-Perez G, Israel DA, Peek RM Jr.

Am J Pathol. 2011 Apr;178(4):1448-52. doi: 10.1016/j.ajpath.2010.12.018. Epub 2011 Mar 4.

17.

Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk.

de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R, Bravo LE, Sicinschi LA, Delgado AG, Mera RM, Israel DA, Romero-Gallo J, Peek RM Jr, Cover TL, Correa P, Wilson KT.

Gut. 2011 Sep;60(9):1189-95. doi: 10.1136/gut.2010.234468. Epub 2011 Feb 25.

18.

Genetic Exchange.

Israel DA.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 28.

19.

Surreptitious manipulation of the human host by Helicobacter pylori.

Israel DA, Peek RM.

Gut Microbes. 2010 Mar;1(2):119-127.

20.

Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy.

Goguen LA, Chapuy CI, Sher DJ, Israel DA, Blinder RA, Norris CM, Tishler RB, Haddad RI, Annino DJ.

Otolaryngol Head Neck Surg. 2010 Sep;143(3):367-74. doi: 10.1016/j.otohns.2010.04.020.

PMID:
20723773
21.

Matrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected mice.

Ogden SR, Noto JM, Allen SS, Patel DA, Romero-Gallo J, Washington MK, Fingleton B, Israel DA, Lewis ND, Wilson KT, Chaturvedi R, Zhao Z, Shyr Y, Peek RM Jr.

Cancer Res. 2010 Jan 1;70(1):30-5. doi: 10.1158/0008-5472.CAN-09-2899.

22.

Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial.

Otero HJ, Yap JT, Patak MA, Erturk SM, Israel DA, Johnston CJ, Sakellis C, Rybicki FJ, Van den Abbeele AD, Ros PR.

AJR Am J Roentgenol. 2009 Aug;193(2):326-32. doi: 10.2214/AJR.08.1565.

PMID:
19620427
23.

Delineation of a carcinogenic Helicobacter pylori proteome.

Franco AT, Friedman DB, Nagy TA, Romero-Gallo J, Krishna U, Kendall A, Israel DA, Tegtmeyer N, Washington MK, Peek RM Jr.

Mol Cell Proteomics. 2009 Aug;8(8):1947-58. doi: 10.1074/mcp.M900139-MCP200. Epub 2009 May 25.

24.

Role of Helicobacter pylori CagA molecular variations in induction of host phenotypes with carcinogenic potential.

Schneider N, Krishna U, Romero-Gallo J, Israel DA, Piazuelo MB, Camargo MC, Sicinschi LA, Schneider BG, Correa P, Peek RM Jr.

J Infect Dis. 2009 Apr 15;199(8):1218-21. doi: 10.1086/597416.

25.

Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling.

Nagy TA, Frey MR, Yan F, Israel DA, Polk DB, Peek RM Jr.

J Infect Dis. 2009 Mar 1;199(5):641-51. doi: 10.1086/596660.

26.

Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer.

McClain MS, Shaffer CL, Israel DA, Peek RM Jr, Cover TL.

BMC Genomics. 2009 Jan 5;10:3. doi: 10.1186/1471-2164-10-3.

28.

Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation.

Wroblewski LE, Shen L, Ogden S, Romero-Gallo J, Lapierre LA, Israel DA, Turner JR, Peek RM Jr.

Gastroenterology. 2009 Jan;136(1):236-46. doi: 10.1053/j.gastro.2008.10.011. Epub 2008 Oct 9.

29.

PET/CT appearance of non-Hodgkin lymphoma of the vermiform appendix.

Souza FF, Israel DA.

Clin Nucl Med. 2008 Oct;33(10):694-6. doi: 10.1097/RLU.0b013e318184c8dc. No abstract available.

PMID:
18806571
30.

p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7.

Ogden SR, Wroblewski LE, Weydig C, Romero-Gallo J, O'Brien DP, Israel DA, Krishna US, Fingleton B, Reynolds AB, Wessler S, Peek RM Jr.

Mol Biol Cell. 2008 Oct;19(10):4110-21. doi: 10.1091/mbc.E08-03-0283. Epub 2008 Jul 23.

31.

Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor.

O'Brien DP, Romero-Gallo J, Schneider BG, Chaturvedi R, Delgado A, Harris EJ, Krishna U, Ogden SR, Israel DA, Wilson KT, Peek RM Jr.

J Biol Chem. 2008 Aug 29;283(35):23922-30. doi: 10.1074/jbc.M801144200. Epub 2008 Jun 25.

32.

Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.

Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P, Peek RM Jr.

Cancer Res. 2008 Jan 15;68(2):379-87. doi: 10.1158/0008-5472.CAN-07-0824.

33.

CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor.

Holdsworth CH, Badawi RD, Manola JB, Kijewski MF, Israel DA, Demetri GD, Van den Abbeele AD.

AJR Am J Roentgenol. 2007 Dec;189(6):W324-30.

PMID:
18029844
34.

Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT.

Sheehy N, Israel DA.

Clin Nucl Med. 2007 Oct;32(10):820-1.

PMID:
17885370
35.

Findings on (18)FDG-PET imaging in statin-induced rhabdomyolysis.

Sheehy N, Israel DA.

Clin Radiol. 2007 Oct;62(10):1012-4. Epub 2007 Jul 20. No abstract available.

PMID:
17765468
36.

The role of decay-accelerating factor as a receptor for Helicobacter pylori and a mediator of gastric inflammation.

O'Brien DP, Israel DA, Krishna U, Romero-Gallo J, Nedrud J, Medof ME, Lin F, Redline R, Lublin DM, Nowicki BJ, Franco AT, Ogden S, Williams AD, Polk DB, Peek RM Jr.

J Biol Chem. 2006 May 12;281(19):13317-23. Epub 2006 Mar 16.

37.

The role of persistence in Helicobacter pylori pathogenesis.

Israel DA, Peek RM Jr.

Curr Opin Gastroenterol. 2006 Jan;22(1):3-7. Review.

PMID:
16319669
38.

Role of dprA in transformation of Campylobacter jejuni.

Takata T, Ando T, Israel DA, Wassenaar TM, Blaser MJ.

FEMS Microbiol Lett. 2005 Nov 1;252(1):161-8. Epub 2005 Sep 19.

39.

Activation of beta-catenin by carcinogenic Helicobacter pylori.

Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O'Brien DP, Romero-Gallo J, Peek RM Jr.

Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10646-51. Epub 2005 Jul 18.

40.

Helicobacter pylori protein HP0222 belongs to Arc/MetJ family of transcriptional regulators.

Popescu A, Karpay A, Israel DA, Peek RM Jr, Krezel AM.

Proteins. 2005 May 1;59(2):303-11.

PMID:
15723352
41.

Effect of glycine on Helicobacter pylori in vitro.

Minami M, Ando T, Hashikawa SN, Torii K, Hasegawa T, Israel DA, Ina K, Kusugami K, Goto H, Ohta M.

Antimicrob Agents Chemother. 2004 Oct;48(10):3782-8.

42.

Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity.

Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr.

J Infect Dis. 2004 May 15;189(10):1914-20. Epub 2004 Apr 27.

PMID:
15122529
43.

Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa.

Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM Jr.

Gastroenterology. 2003 Oct;125(4):1125-36.

PMID:
14517796
44.

Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia.

Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, Dangler CA, Israel DA, Krishna U, Gaus K, Peek RM Jr.

Gastroenterology. 2003 Jun;124(7):1879-90.

PMID:
12806621
45.

Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin.

Cover TL, Krishna US, Israel DA, Peek RM Jr.

Cancer Res. 2003 Mar 1;63(5):951-7.

46.

Characterization of expression of a functionally conserved Helicobacter pylori methyltransferase-encoding gene within inflamed mucosa and during in vitro growth.

Takeuchi H, Israel DA, Miller GG, Donahue JP, Krishna U, Gaus K, Peek RM Jr.

J Infect Dis. 2002 Oct 15;186(8):1186-9. Epub 2002 Sep 25.

PMID:
12355374
47.

Inactivation of a Helicobacter pylori DNA methyltransferase alters dnaK operon expression following host-cell adherence.

Donahue JP, Israel DA, Torres VJ, Necheva AS, Miller GG.

FEMS Microbiol Lett. 2002 Mar 5;208(2):295-301.

48.

Helicobacter pylori genetic diversity within the gastric niche of a single human host.

Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, Falkow S, Peek RM Jr.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14625-30. Epub 2001 Nov 27.

49.

Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease.

Kidd M, Peek RM, Lastovica AJ, Israel DA, Kummer AF, Louw JA.

Gut. 2001 Nov;49(5):629-35.

50.

pathogenesis of Helicobacter pylori-induced gastric inflammation.

Israel DA, Peek RM.

Aliment Pharmacol Ther. 2001 Sep;15(9):1271-90. Review.

Supplemental Content

Loading ...
Support Center